Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 947 results for "daiichi sankyo"

Daiichi Sankyo launches seven new 'premium generics'
Pharma Letter

Daiichi Sankyo Espha launches seven new generic drugs

Daiichi Sankyo Company, Limited, a Japan-based pharmaceutical company, has announced that its generics subsidiary, Daiichi Sankyo Espha, has launched seven new generic drugs with four new active ingredients. The products names are: Naftopidil OD ..., 2 days ago

118 images for daiichi sankyo

Pharma Letter, 1 week ago
Financial Express, 2 weeks ago
Drug Discovery and Development, 1 week ago, 2 weeks ago
MDLinx, 1 week ago
Pharmaceutical Business Review, 2 weeks ago, 2 weeks ago
Review Seeker, 1 month ago
PR Newswire, 1 month ago
Business Today India, 2 months ago

Daiichi Sankyo and UCB submit MAA for seizure therapy in Japan

Daiichi Sankyo Company, Limited, a Japanese pharmaceutical company, and UCB Japan Co., Ltd, a biopharmaceutical company, have submitted marketing authorization application, or MAA, for lacosamide in Japan as adjunctive therapy in the treatment of ...
 Individual.com1 day ago Daiichi, UCB seek marketing authorization for epilepsy drug in Japan  CPhI.cn4 days ago UCB seeks marketing authorization for lacosamide in Japan to treat epilepsy  PharmaBiz6 days ago
European Pharmaceutical Review

Daiichi Sankyo receives EC marketing authorization for stroke prevention drug

The Hokusai-VTE study demonstrated that LIXIANA effectively reduces symptomatic recurrent VTE, including DVT and fatal and non-fatal PE risk across a broad range of patients (3.2% vs. 3.5% of patients, LIXIANA 60 mg vs. warfarin respectively; HR, ...
 Individual.com1 week ago EU grants marketing nod to Daiichi Sankyo's once-daily Lixiana for stroke prevention in adult patients with NVAF  PharmaBiz1 week ago EC approves Lixiana for stroke prevention in nonvalvular atrial fibrillation and for the treatment and prevention of DVT and PE  European Pharmaceutical Review1 week ago LIXIANA approved in the EU for stroke prevention in nonvalvular atrial fibrillation and for the treatment and prevention of recurrent DVT and PE  Medical News Today1 week ago
Business Standard

Zenotech Labs to be referred to BIFR

Sun Pharma, Daiichi Sankyo together hold 66.85% shares of the company BS Reporter May 26, 2015 Last Updated at 20:30 IST The board of directors of Hyderabad-based Zenotech Laboratories Limited, which is now in the hands of Sun Pharmaceutical Industries ...
 Business Standard1 month ago Shanghvi did not buy Daiichi Sankyo's shares: Sun Pharma  Rediff.com2 months ago Daiichi exits Sun; shares slump 9 per cent  Asian Age2 months ago Sun Pharma sees biggest fall in 5 years  Economic Times2 months ago
India Infoline

Daiichi Sankyo eyes Japan as US patent revenue loss looms

TOKYO -- Pharmaceutical giant Daiichi Sankyo aims to boost sales in Japan and streamline research and developmentto counter a dent in revenue set to kick in next year from the expiration of the U.S. patent for olmesartan,its popular drug to combat ...
 Nikkei Asian Review1 month ago Daiichi Sankyo's India exit, a Credit Positive  India Infoline2 months ago Sun Pharma tanks 11% on Daiichi exit  Times of India2 months ago Sun Pharma Slumps Over 10% as Daiichi Exits  NDTV2 months ago

Japan's MHLW lifts prescription period limitation for Daiichi Sankyo's antiplatelet agent

Based on a notification received from the Japanese Ministry of Health, Labour and Welfare, Daiichi Sankyo Company Limited has announced that the antiplatelet agent Efient 3.75mg/5mg Tablets (Prasugrel Hydrochloride), which was launched in Japan in ...
 Bio Spectrum Asia1 month ago

BSE gains over 100 points as markets regain some ground

Sun Pharma, which lost over 10% of its value on Tuesday after Daiichi Sankyo announced exiting the company by selling all its shares, gained over 2% on the NSE in morning trade.
 DNA2 months ago Sun Pharma stock tank 11% as Daiichi makes a dash for exit  DNA2 months ago Daiichi Sankyo decides to exit Sun Pharma stock  DNA2 months ago
India Infoline

Sun Pharma shares bounce back, up 3 pc on bourses

made a comeback at the bourses today, rising nearly 3 per cent, a day after Japanese drugmaker Daiichi Sankyo sold its entire stake of around 9 per cent in the company for Rs 20,025 crore. After making a positive opening, shares of the company further gained ...
 Business Standard2 months ago Daiichi deal blows 11% off Sun Pharma stock price  The Financial Chronicle2 months ago Sun Pharma slumps 9% on Daiichi exit  India Infoline2 months ago Sun dips nearly 9%;top loser on Sensex, Nifty as Daiichi exits  Business Standard2 months ago

Daiichi Sankyo's $3.6 billion exit from Sun Pharma hits rupee, stocks

fell to a three-and-a-half month low on Tuesday and stocks sank to their lowest in nearly four weeks on concerns about foreign outflows after Japan's Daiichi Sankyo's $3.6 billon share sale in Sun Pharmaceutical Industries. Daiichi Sankyo began the sale late ...
 Economic Times2 months ago Daiichi's exit from Sun Pharma hits rupee, stocks  Sify2 months ago

Daiichi Sankyo sells Sun Pharma stake in block deals; stock plunges

By ECONOMICTIMES.COM | 21 Apr, 2015, 09.47AM IST Post a Comment MUMBAI: Shares of Sun Pharmaceuticals were under selling pressure and plunged as much as 10.63 per cent in intraday trade as Daiichi Sankyo offloaded its entire stake in the company through ...
 Economic Times2 months ago Sun Pharma cracks 11% as Daiichi exits; should investors buy it?  Economic Times2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - daiichi sankyo
Get updated on latest news & your favorite topics right in your inbox!
More     Less